Evaxion Biotech is a biotechnology business based in the US. Evaxion Biotech shares (EVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.74 – an increase of 16.87% over the previous week. Evaxion Biotech employs 46 staff and has a trailing 12-month revenue of around $3.3 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.74 |
|---|---|
| 52-week range | $1.20 - $20.81 |
| 50-day moving average | $1.64 |
| 200-day moving average | $7.78 |
| Wall St. target price | $13.25 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-10.00 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.7414 from 2025-05-16
| 1 week (2025-05-09) | 16.87% |
|---|---|
| 1 month (2025-04-17) | 33.03% |
| 3 months (2025-02-18) | -33.02% |
| 6 months (2024-11-18) | 6.83% |
| 1 year (2024-05-17) | -53.19% |
|---|---|
| 2 years (2023-05-18) | -97.98% |
| 3 years (2022-05-18) | 90.5 |
| 5 years (2020-05-14) | N/A |
| Revenue TTM | $3.3 million |
|---|---|
| Gross profit TTM | $3.3 million |
| Return on assets TTM | -72.57% |
| Return on equity TTM | -802.8% |
| Profit margin | 0% |
| Book value | $-1.18 |
| Market Capitalization | $9.4 million |
TTM: trailing 12 months
We're not expecting Evaxion Biotech to pay a dividend over the next 12 months.
You may also wish to consider:
Evaxion Biotech's shares were split on a 1:5 basis on 13 January 2025 . So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evaxion Biotech shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Evaxion Biotech shares which in turn could have impacted Evaxion Biotech's share price.
Over the last 12 months, Evaxion Biotech's shares have ranged in value from as little as $1.2 up to $20.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evaxion Biotech's is -0.231. This would suggest that Evaxion Biotech's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Evaxion Biotech has bucked the trend.
To put Evaxion Biotech's beta into context you can compare it against those of similar companies.
Evaxion Biotech A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark. .
We dug through 60 years of Berkshire Hathaway annual shareholder letters to bring you 9 lessons from Warren Buffett: “The Oracle of Omaha.”
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.